https://prabadinews.com/
  • October 10, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Medical Supplies

Wistron increases investment in the US, doubling capital expenditure for California subsidiary

Wistron’s board of directors approved a significant increase in the capital expenditure budget for its Fremont, California-based wholly-owned subsidiary WisLab…

Taiwan Mobile forecasts 30% rise in iPhone 17 sales, driven by upgrade replacements from older models

Apple officially unveiled its latest iPhone 17 series on September 10, and Taiwan Mobile’s Chief Consumer Business Officer, Tony Lin,…

Taiwan wafer foundry industry, 3Q 2025

Taiwan wafer foundry revenue is estimated to rise mildly in the second half of 2025 from the first half, influenced…

PCV21 Shows Favorable Immunogenicity in Infants, Toddlers Receiving Pediatric Vaccines

The 21-valent pneumococcal conjugate vaccine (PCV21) elicited favorable immunogenicity and safety in infants and toddlers who were coadministered common pediatric…

Balancing Efficacy and Safety: Navigating Dose Adjustments and Therapy Optimization in Myelofibrosis

Jessica Lewis-Gonzalez, PharmD, BCOP, discusses the management of hematologic and non-hematologic toxicities in cancer patients, emphasizing the importance of proactive…

Exploring the Antidepressant Potential of GLP-1 Receptor Agonists

GLP-1 receptor agonists show promise in alleviating depressive symptoms in patients with type 2 diabetes, offering a potential dual benefit…

Aficamten Emerges as a Potential First-Line Therapy in Hypertrophic Cardiomyopathy

Michael Fifer, MD, discusses the Maple HCM study, which compared the cardiac myosin inhibitor Aficamten and the beta blocker Metoprolol…

Starbucks deploys inventory-taking AI tool

The computer vision technology helps the chain track its in-store stock and may soon be able to automate some ordering.

Universal Postal Union deploys post-de minimis tool

The agency’s landed cost calculator aims to help mail carriers resume U.S.-bound shipments after the exemption’s elimination.

Zidesamtinib Shows Clinically Meaningful Activity, Durability in ROS1+ NSCLC

The treatment was generally well-tolerated in patients with ROS1-positive (ROS1+) non–small cell lung cancer (NSCLC).